posted on 2023-03-31, 04:07authored bySnehal Midge
This study aimed to design a novel platform to capture the breast cancer biomarker. Human Epidermal Growth Factor Receptor-HER2, for cancer diagnosis at an earlier stage. The diagnostic platform also provides timely insights for commencement of appropriate therapeutic solutions in order to curb the disease at the first instance.